Novartis
NVS
NVS
943 hedge funds and large institutions have $22.9B invested in Novartis in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 347 increasing their positions, 339 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.17% more ownership
Funds ownership: 9.67% → 9.84% (+0.17%)
2% less capital invested
Capital invested by funds: $23.3B → $22.9B (-$451M)
12% less funds holding in top 10
Funds holding in top 10: 69 → 61 (-8)
Holders
943
Holding in Top 10
61
Calls
$78.6M
Puts
$33.6M
Top Buyers
| 1 | +$153M | |
| 2 | +$95.8M | |
| 3 | +$90.9M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$65.3M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$40.4M |
Top Sellers
| 1 | -$203M | |
| 2 | -$52.4M | |
| 3 | -$44.3M | |
| 4 |
Neuberger Berman Group
New York
|
-$38.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$35.5M |